RI
Richard I Steinhart
DELAYED 1 MONTH
Chief Financial Officer; Director
ATOSSA THERAPEUTICS, INC.
BioXcel Therapeutics, Inc.
Filings
4
Companies
2
Latest
May 12, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
76
BTAICLUSTER 4
BioXcel Therapeutics, Inc.
Richard I Steinhart
Chief Financial Officer
Sale
$7.4K
6,845 sh
May 22 11:01 PM
May 20, 2026
—
BioXcel Therapeutics, Inc.
Richard I Steinhart
Chief Financial Officer
Option Exercise
—
17,500 sh
May 22 11:01 PM
May 4, 2026
—
BioXcel Therapeutics, Inc.
Richard I Steinhart
Chief Financial Officer
Option Exercise
—
9,000 sh
May 7 11:01 PM
May 1, 2026
—
BioXcel Therapeutics, Inc.
Richard I Steinhart
Chief Financial Officer
Option Exercise
—
35 sh
Mar 17 12:04 AM
Mar 15, 2026
—
BioXcel Therapeutics, Inc.
Richard I Steinhart
Chief Financial Officer
Option Exercise
—
33 sh
Mar 17 12:04 AM
Mar 14, 2026